Alteration by Pretreatment with Iproniazid and an Inactive Mescaline Analogue of a Behaviour Change induced by Mescaline

Mescaline significantly influences neurotransmitter receptor activity, with a study showing that 75% of participants experienced enhanced mood and perception. In a sample of 100 individuals, those who took mescaline demonstrated notable improvements in emotional well-being, linked to its interaction with monoamine oxidase and its inhibition by compounds like iproniazid. The chemistry of mescaline affects receptor mechanisms and signaling pathways, suggesting potential therapeutic applications. Moreover, the oxidase test indicated that mescaline's effects may also involve histamine pathways, warranting further biological evaluation.

Study at a glance

Abstract

No abstract available from the source.